Ayer DW - Search Results

1

Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.

Ford JH, Stauffer VL, McAllister P, Akkala S, Sexson M, Ayer DW, Wang S. Ford JH, et al. Among authors: ayer dw. Qual Life Res. 2021 Feb;30(2):465-466. doi: 10.1007/s11136-020-02720-1. Qual Life Res. 2021. PMID: 33340061 Free PMC article. No abstract available.

2

Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab.

Ayer DW, Skljarevski V, Ford JH, Nyhuis AW, Lipton RB, Aurora SK. Ayer DW, et al. Headache. 2018 Sep;58(8):1225-1235. doi: 10.1111/head.13383. Epub 2018 Aug 14. Headache. 2018. PMID: 30106172 Clinical Trial.

3

Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.

Speck RM, Shalhoub H, Wyrwich KW, Yu R, Ayer DW, Ford J, Bush EN, Lipton RB. Speck RM, et al. Among authors: ayer dw. Headache. 2019 May;59(5):756-774. doi: 10.1111/head.13497. Epub 2019 Mar 12. Headache. 2019. PMID: 30861580 Free PMC article. Clinical Trial.

4

Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.

Ford JH, Ayer DW, Zhang Q, Carter JN, Leroux E, Skljarevski V, Aurora SK, Tockhorn-Heidenreich A, Lipton RB. Ford JH, et al. Among authors: ayer dw. Neurology. 2019 Jul 30;93(5):e508-e517. doi: 10.1212/WNL.0000000000007856. Epub 2019 Jul 3. Neurology. 2019. PMID: 31270220 Free PMC article. Clinical Trial.

5

Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome.

Speck RM, Shalhoub H, Ayer DW, Ford JH, Wyrwich KW, Bush EN. Speck RM, et al. Among authors: ayer dw. J Patient Rep Outcomes. 2019 Jul 11;3(1):39. doi: 10.1186/s41687-019-0138-x. J Patient Rep Outcomes. 2019. PMID: 31297622 Free PMC article.

6

Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN).

Ford J, Tassorelli C, Leroux E, Wang S, Ayer D, Nichols R, Detke H. Ford J, et al. Qual Life Res. 2021 Jan;30(1):105-115. doi: 10.1007/s11136-020-02623-1. Epub 2020 Sep 15. Qual Life Res. 2021. PMID: 32930994 Free PMC article. Clinical Trial.

7

Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.

Ford JH, Stauffer VL, McAllister P, Akkala S, Sexson M, Ayer DW, Wang S. Ford JH, et al. Among authors: ayer dw. Qual Life Res. 2021 Feb;30(2):455-464. doi: 10.1007/s11136-020-02632-0. Epub 2020 Sep 17. Qual Life Res. 2021. PMID: 32944843 Free PMC article. Clinical Trial.

8

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.

Ford JH, Kurth T, Starling AJ, Ayer DW, Wietecha LA, Port MD, Rettiganti M, Ruff DD. Ford JH, et al. Among authors: ayer dw. Headache. 2020 Nov;60(10):2304-2319. doi: 10.1111/head.14013. Headache. 2020. PMID: 33249580 Free PMC article. Clinical Trial.

9

Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.

Speck RM, Yu R, Ford JH, Ayer DW, Bhandari R, Wyrwich KW. Speck RM, et al. Among authors: ayer dw. Headache. 2021 Mar;61(3):511-526. doi: 10.1111/head.14031. Epub 2021 Jan 22. Headache. 2021. PMID: 33481276 Free PMC article. Clinical Trial.

10

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.

Ford JH, Ye W, Ayer DW, Mi X, Bhandari S, Buse DC, Lipton RB. Ford JH, et al. Among authors: ayer dw. J Patient Rep Outcomes. 2023 Apr 4;7(1):34. doi: 10.1186/s41687-023-00552-4. J Patient Rep Outcomes. 2023. PMID: 37016181 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters